Zevra Therapeutics, Inc. ZVRA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $37.89M+211% | $12.17M+2,336% | -$544K-101% | $74.71M+2,511% | -$3.1M+91.3% | ||
| $368K+1.7% | $362K-7.7% | $392K-76.3% | $1.65M+0.1% | $1.65M+0.1% | ||
| $3.11M-27.5% | $4.28M+54.6% | $2.77M+12.5% | $2.46M-20.9% | $3.12M-22.5% | ||
| $6.14M— | —— | —— | -$3.6M+56.2% | -$8.22M+49.4% | ||
| $35K— | $0-100% | $554K+160% | $213K+115% | $99K— | ||
| $79.62M+34,974% | $227K— | —— | $11.93M+13.2% | $10.54M+293% | ||
| $60.09M— | $0— | $0— | $0— | $0— | ||
| -$52.8M-2,174% | $2.55M-61.0% | $6.53M+373% | $1.38M-14.1% | $1.61M+102% | ||
| $33.19M+317% | $7.97M+18.4% | $6.73M-35.1% | $10.37M+192% | $3.56M+118% | ||
| $6.11M— | —— | —— | -$3.81M+54.2% | -$8.32M+48.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Zevra Therapeutics, Inc. generate?
- Zevra Therapeutics, Inc. (ZVRA) generated -$21.9M in operating cash flow over the trailing twelve months.
- What is Zevra Therapeutics, Inc.'s free cash flow?
- After $802.0K of capital expenditures, Zevra Therapeutics, Inc.'s free cash flow was -$22.3M over the trailing twelve months, up 68.0% year over year.
- Where does Zevra Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Zevra Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
